EXPERIENCE OF ORNITHINE ASPARTATE (HEPA-MERZ) AND PROBIOTICS BIOFLORUM FORTE IN THE TREATMENT OF NON-SEVERE FORMS OF ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE

類似資料

• Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
  著者:: Roger F. Butterworth, 等
  出版事項: (2019-03-01)
• Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
  著者:: Butterworth, Roger F., 等
  出版事項: (2018)
• Non-alcoholic Steatohepatitis: An Overview
  著者:: Allison Shifflet, 等
  出版事項: (2009-01-01)
• POSSIBILITIES TO USE L-ORNITINE-L-ASPARTATE IN THERAPY OF NON-ALCOHOL FATTY LIVER DISEASE PATIENTS
  著者:: L. A. Teterina, 等
  出版事項: (2017-11-01)
• l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
  著者:: Canbay, Ali, 等
  出版事項: (2019)